Health Care, Local News, Science

New five-year Sotyktu (deucravacitinib) data shows consistent safety and durable response rates in moderate-to-severe plaque psoriasis

No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu safety profile Following five years of continuous Sotyktu treatment, clinical response was maintained in nearly half of patients for Psoriasis Area and

Health Care, Lifestyle, Local News, Science

UroGen announces results from subgroup analyses of the pivotal ENVISION trial evaluating impact of baseline tumor burden and focality on response to UGN-102

Results presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU 2025) Treatment with UGN-102 resulted in durable complete response (CR) rates across subgroups with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) CR rates were: 82.8% for patients

Business, Energy & Power, Lifestyle, Science

Pioneer Power renews on-site power service agreement with large US retailer for estimated $2M in annual revenue over three years

FORT LEE, N.J. — (BUSINESS WIRE) — Pioneer Power Solutions, Inc. (Nasdaq: PPSI) (“Pioneer” or the “Company”), a leader in the design, manufacture, service and integration of distributed energy resources, power generation equipment and mobile electric vehicle (“EV”) charging solutions, on Thursday

Business, Media & Communications, News Now!, Technology

Tilson and Sitetracker celebrate a decade of innovation, transforming infrastructure delivery across the country

MONTCLAIR, N.J. — (BUSINESS WIRE) — Tilson, a national leader in network development and information infrastructure professional services, and Sitetracker, the leading full asset lifecycle management platform, have marked 10 years of transformative collaboration in large-scale infrastructure delivery.     A key